- Home
- TRVI vs SLQT Comparison
TRVI vs SLQT Comparison
Compare TRVI & SLQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- SLQT
- Stock Information
- Founded
- TRVI 2011
- SLQT 1999
- Country
- TRVI United States
- SLQT United States
- Employees
- TRVI N/A
- SLQT N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- SLQT Specialty Insurers
- Sector
- TRVI Health Care
- SLQT Finance
- Exchange
- TRVI Nasdaq
- SLQT Nasdaq
- Market Cap
- TRVI 629.8M
- SLQT 566.4M
- IPO Year
- TRVI 2019
- SLQT 2020
- Fundamental
- Price
- TRVI $5.83
- SLQT $2.11
- Analyst Decision
- TRVI Strong Buy
- SLQT Hold
- Analyst Count
- TRVI 8
- SLQT 2
- Target Price
- TRVI $19.31
- SLQT $3.38
- AVG Volume (30 Days)
- TRVI 1.0M
- SLQT 1.3M
- Earning Date
- TRVI 05-08-2025
- SLQT 05-12-2025
- Dividend Yield
- TRVI N/A
- SLQT N/A
- EPS Growth
- TRVI N/A
- SLQT N/A
- EPS
- TRVI N/A
- SLQT N/A
- Revenue
- TRVI N/A
- SLQT $1,488,701,000.00
- Revenue This Year
- TRVI N/A
- SLQT $15.45
- Revenue Next Year
- TRVI N/A
- SLQT $12.78
- P/E Ratio
- TRVI N/A
- SLQT N/A
- Revenue Growth
- TRVI N/A
- SLQT 20.41
- 52 Week Low
- TRVI $2.30
- SLQT $1.62
- 52 Week High
- TRVI $7.39
- SLQT $6.86
- Technical
- Relative Strength Index (RSI)
- TRVI 56.14
- SLQT 31.09
- Support Level
- TRVI $6.08
- SLQT $2.11
- Resistance Level
- TRVI $6.47
- SLQT $2.23
- Average True Range (ATR)
- TRVI 0.39
- SLQT 0.10
- MACD
- TRVI -0.00
- SLQT 0.02
- Stochastic Oscillator
- TRVI 45.06
- SLQT 6.08
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.